FDA Approval of Long-Acting PrEP Marks Milestone in HIV Prevention—But Raises Urgent Questions About Access and Equity
FDA Approval of Long-Acting PrEP Marks Milestone in HIV Prevention—But Raises Urgent Questions About Access and Equity WASHINGTON, DC, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- This week marks a pivotal development in the fight against …